Form 4 for KEQU KEWAUNEE SCIENTIFIC CORP /DE/
Accepted 2022-08-29 00:00:00 ET · period of report 2022-08-26 · accession 0001262059-22-000003 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-08-29 | 2022-08-26 | KEQU | RINDOKS KURT P | VP - Gbl Prod Development | F - Tax | $19.88 | -2,560 | 15.0K | -15% | -$50.9K |
| D | 2022-08-29 | 2022-08-26 | KEQU | RINDOKS KURT P | VP - Gbl Prod Development | M - OptEx | $16.97 | +3,000 | 17.5K | +21% | +$50.9K |
| D | 2022-08-29 | 2022-08-26 | KEQU | RINDOKS KURT P | VP - Gbl Prod Development | M - OptEx | $0.00 | -3,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-08-26 | F | D | 2,560 | $19.88 | 14,986 | D | — | — | |
| 2 | Common | Common Stock | 2022-08-26 | M | A | 3,000 | $16.97 | 17,546 | D | — | — | (F1) Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon exercise as reported below on this Form 4 report. |
| 3 | Derivative | Option to Buy FY16 | 2022-08-26 | M | D | 3,000 | $0.00 | 0 | D | $16.97 · 2019-08-26 to 2025-08-26 | 3,000 Common Stock | (F2) Employee stock option granted under Employee Stock Option plan under Rule 16b-3. |